Safety Alert: Bupropion

Recall of selected 300mg tablets

GlaxoSmithKline Inc and Biovail Corp have initiated a recall of selected bottles of 300mg WELLBUTRIN XL tablets. These tablets may contain foreign material embedded in the tablets.

The recall applies to:

WELLBUTRIN XL 300mg tablets Lot: P08A011, Exp May-09

Source: FDA
Publication Date: 2008-Mar-27
Last Updated: 2009-Dec-06

What does this mean?

If you are using WELLBUTRIN XL, check to find out (a) who it was made by, and (b) what strength your tablets are. If your tablets are made by GlaxoSmithKline or Biovail Corp, and your bottle has an expiry and/or "lot" number printed on it that matches the date/numbers listed in the recall above, you should return them to your pharmacy to examine and possibly exchange.

If you are not sure who has made your tablets, or cannot find an expiry date or "lot" number, please take your bottle to your pharmacist for them to check.

Visit the medication page for the following drugs:
Bupropion medication page

DISCLAIMER: iGuard is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Bookmark and Share